Диссертация (1139946), страница 28
Текст из файла (страница 28)
Coll. Cardiol.-2009. — V. 53. — № 17. — P. 1510–1516.171.Witchitz S., Darmon J.Y. Nicorandil safety in the long-term treatment ofcoronary head desease / Cardiovasc.Drugs. Ther - 1995. - № 2. – Р.237-243.172.Xia Wu C, Shin Tan W, Han Sim Toh MP, et al. Derivation andvalidation of a risk index to predict all-cause mortality in type 2 diabetes mellitus/ J Endocrinol Metabol. – 2012. - №2(2).
– Р.88-95.173.Yu-Xiang, Yan. Development and Avaluation of a Questionnaire forMeasuring Suboptimal Health Status in Urban Chinese // Yu-Xiang, Yan, YouQin Liu, Man Li at al. / J. Epidemiol. - 2009. -№3. - P. 327-342.174.Yu-Xiang, Yan. Association of Suboptimal Health Status CardiovascularRisk Factorsin Urban ChineseWorkers / J. of Urban Health: Bulletin of the NewYork Academi Medicine.
- 2011. - Р. 415.175.Zhu W.L., Shan Y.D, Guo J.X. еt al. Double-blind, multicenter,activecontrolled, randomized clinical trial to assess the safety and efficacy oforally administered nicorandil in patients with stable angina pectoris in China/Circ J. - 2007.- №71(6). – Р.826–833..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
